Product NDC: | 54859-110 |
Proprietary Name: | Dologesic |
Non Proprietary Name: | Acetaminophen, Phenyltoloxamine Citrate |
Active Ingredient(s): | 500; 30 mg/1; mg/1 & nbsp; Acetaminophen, Phenyltoloxamine Citrate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54859-110 |
Labeler Name: | LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part343 |
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Start Marketing Date: | 20090901 |
Package NDC: | 54859-110-10 |
Package Description: | 100 TABLET in 1 BOTTLE (54859-110-10) |
NDC Code | 54859-110-10 |
Proprietary Name | Dologesic |
Package Description | 100 TABLET in 1 BOTTLE (54859-110-10) |
Product NDC | 54859-110 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Acetaminophen, Phenyltoloxamine Citrate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20090901 |
Marketing Category Name | OTC MONOGRAPH NOT FINAL |
Labeler Name | LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION |
Substance Name | ACETAMINOPHEN; PHENYLTOLOXAMINE CITRATE |
Strength Number | 500; 30 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes |